Cargando…

Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma

OBJECTIVE: The latest research proposed a novel copper-dependent programmed cell death named cuproptosis. We aimed to elucidate the influence of cuproptosis in clear cell renal cell carcinoma (ccRCC) from a multi-omic perspective. METHODS: This study systematically assessed mRNA expression, methylat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Maoshu, Li, Yongsheng, Wang, Yun, Lin, Pingli, Mi, Jun, Zhong, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362584/ https://www.ncbi.nlm.nih.gov/pubmed/37481601 http://dx.doi.org/10.1186/s40001-023-01221-4

Ejemplares similares

Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma
por: Zhong, Weimin, et al.
Publicado: (2022)

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
por: Chu, Binxiang, et al.
Publicado: (2022)

Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
por: Xu, Jiahao, et al.
Publicado: (2022)

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma
por: Hong, Peng, et al.
Publicado: (2022)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
por: Mei, Wangli, et al.
Publicado: (2022)

Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
por: Luo, Gang, et al.
Publicado: (2023)

Multi-omics approach reveals the secrets of metabolism of clear cell—renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2016)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator FDX1 in Clear Cell Renal Cell Carcinoma
por: Zeng, Song, et al.
Publicado: (2022)

Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2022)

Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Guo, Tuanjie, et al.
Publicado: (2022)

Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
por: Huang, Shuaishuai, et al.
Publicado: (2023)

Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis
por: Zhong, Weimin, et al.
Publicado: (2021)

Multi-Omics Uncover Neonatal Cecal Cell Development Potentials
por: Chen, Liang, et al.
Publicado: (2022)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer
por: Fang, Kun, et al.
Publicado: (2022)

Identification of 12 immune-related lncRNAs and molecular subtypes for the clear cell renal cell carcinoma based on RNA sequencing data
por: Zhong, Weimin, et al.
Publicado: (2020)

A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
por: Bian, Zilong, et al.
Publicado: (2022)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
por: Wang, Bao, et al.
Publicado: (2022)

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
por: Shen, Junlin, et al.
Publicado: (2023)

Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma
por: Wang, Hu, et al.
Publicado: (2023)

Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis
por: Liu, Pengfei, et al.
Publicado: (2020)

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma
por: Jiang, Yuxiong, et al.
Publicado: (2022)

Multi-Omics Approach Reveals Redox Homeostasis Reprogramming in Early-Stage Clear Cell Renal Cell Carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Multi-Omics Approaches in Immunological Research
por: Chu, Xiaojing, et al.
Publicado: (2021)

TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT
por: Zhong, Mengya, et al.
Publicado: (2020)

Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma
por: Long, Shichao, et al.
Publicado: (2022)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Multi-omics analysis reveals prognostic and therapeutic value of cuproptosis-related lncRNAs in oral squamous cell carcinoma
por: Li, Xiaoguang, et al.
Publicado: (2022)

Single-cell and genetic multi-omics analysis combined with experiments confirmed the signature and potential targets of cuproptosis in hepatocellular carcinoma
por: Cao, Feng, et al.
Publicado: (2023)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
por: Cai, Zhiyong, et al.
Publicado: (2022)

Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma
por: Zhang, Ganghua, et al.
Publicado: (2022)

Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
por: Ji, Zhong-Hao, et al.
Publicado: (2022)

Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma
por: Zheng, Wenzhong, et al.
Publicado: (2021)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
por: Bai, Zhixun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0pl30uni2e9asm5s21qvd43tfd